About IPPOSI

A unique partnership of Patients' Organisations, Science and Industry on the island of Ireland.IPPOSI provides a structured way of facilitating interaction between these three key membership groups and where possible with State Agencies on policy, legislation and regulation around the development of new medicines, products, devices and diagnostics for unmet medical needs in Ireland. Read more...


Patient Video Diaries

ipposi_video_t
IPPOSI have asked people to describe to the public what life is like living with a rare disease in Ireland.

Events Calendar

« < June 2013 > »
M T W T F S S
27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
Access to Medicines
HTA Information Day PDF Print E-mail
Wednesday, 14 December 2011 15:34

HTA Information Day

Download Report

 
Outcome Report from IPPOSI Roundtable on Access to new Treatments and Therapies PDF Print E-mail
Thursday, 11 October 2012 15:13

roundtableDOWNLOAD THE REPORT

In June 2012, IPPOSI (the Irish Platform for Patient Organisations, Science and Industry) facilitated a roundtable discussion with its members and invited guests, on the issue of Access to Innovation. The Board of IPPOSI decided to call this meeting in response to reports of treatments which had been approved for reimbursement but were not reaching patients. IPPOSI asked key patient organisations to outline the issues and clarify the situation for their patient members. Key contributions were made by the Irish Cancer Society, MS Ireland and Fighting Blindness.

Read more...
 
Access to Medicines and New Medical Technologies in the Era of Health Technology Assessments in Ireland - Outcome Report PDF Print E-mail
Thursday, 25 June 2009 15:15

The outcome report from the IPPOSI meeting "Access to Medicines and New Medical Technologies in the Era of Health Technologies in Ireland" was launched at the first in a series of IPPOSI Lunch Talks. The report launch took place on Thursday 28 May 2009 in the European Public Information Centre (EPIC) in European Union House, 18 Dawson Street, Dublin 2. Please click here to view this report.

 
Access to Medicines and New Medical Technologies in the Era of Health Technology Assessments in Ireland, Croke Park Stadium, Monday 24th November 2008 PDF Print E-mail
Monday, 25 February 2008 12:23
On Monday 24th November 2008, a major international conference was held in Croke Park, Dublin by IPPOSI and addressed by Minister for Children and Youth Affairs, Barry Andrews TD. This conference examined the role of Health Technology Assessments (HTAs) and their impact on Ireland's healthcare system.

A copy of the agenda is available here and the conference programme is available by clicking here.

Please click here for a copy of the press release.

 

 
IPPOSI Information Day - Health Technology Assessments: The Theory and Practice PDF Print E-mail
Friday, 05 October 2012 11:03

hta_downloadIPPOSI Information Day - Health Technology Assessments: The Theory and Practice

Downloads:

On the 11th of October, IPPOSI held an important information day regarding Health Technology Assessments. A panel of expert speakers introduced those attending to the principles of pharmacoeconomics and the methodology used in the HTA process in Ireland. Speakers identified the data sources used and the criteria which they apply when reaching decisions. Participants also heard about other European systems of assessment and the involvement of patients in these HTA processes.

 

Read more...
 
Access to Innovation Roundtable PDF Print E-mail
Thursday, 03 May 2012 10:39

IPPOSI Access to Innovaiton meeting

roundtableaccess

 

The Round Table on Access to innovaiton took place on Wednesday 6th June 2012 at 3pm and was held in European Parliment Information Centre, Molesworth Street, Dublin 2

The event was open to IPPOSI Members and invited contributors.

At the event IPPOSI facilitated a roundtable discussion with members on Access to Innovation. The Board of IPPOSI decided to call this meeting in response to reports of treatments (drugs and technologies) which have been approved for reimbursement but are not reaching patients. IPPOSI have asked key patient organisations to outline the current issues and clarify the situation for their patient members. In the discussion, we will address the wider view on the systems used to approve innovative therapies rather than focusing on specifics. As an outcome from this meeting we hope to identify key recommendations to be presented to decision makers.